Trials / Completed
CompletedNCT04732728
LUX-Dx Insertable Cardiac Monitor Remote Programming and Performance Study
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 727 (actual)
- Sponsor
- Boston Scientific Corporation · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The LUX-Dx PERFORM Study had two primary objects which were (1) to characterize, in a general patient population, the utilization of the remote programming feature of the Boston Scientific (BSC) Insertable Cardiac Monitor (ICM) device and (2) to collect data to characterize the performance of arrhythmia detection algorithms. Data was also collected to characterize the ICM system related safety events.
Conditions
Timeline
- Start date
- 2021-03-05
- Primary completion
- 2023-05-18
- Completion
- 2023-05-18
- First posted
- 2021-02-01
- Last updated
- 2024-11-25
- Results posted
- 2024-11-25
Locations
24 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT04732728. Inclusion in this directory is not an endorsement.